Comparison of the effects between animal-derived trypsin and recombinant trypsin on human skin cells proliferation, gene and protein expression

Cell and Tissue Banking

Volumn 15, Issue 1, 2014, Pages 41-49

  Manira, Maarof ^a   Khairul Anuar, Khairoji ^a   Seet, Wan Tai ^a   Ahmad Irfan, Abd Wahab ^a   Ng, Min Hwei ^a   Chua, Kien Hui ^a,b   Mohd Heikal, Mohd Yunus ^a,b   Aminuddin, Bin Saim ^a,c   Ruszymah, Bt Hj Idrus ^a,b  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^c Ampang Puteri Specialist Hospital Malaysia   (Malaysia)

Author keywords

Animal derived trypsin; Fibroblasts; Keratinocytes; Recombinant trypsin; Tissue engineering

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKERATIN 10; CYTOKERATIN 14; KRT10 PROTEIN, HUMAN; KRT14 PROTEIN, HUMAN; RECOMBINANT PROTEIN; TRYPSIN;

ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; HUMAN; KERATINOCYTE; PROTEIN SYNTHESIS; SKIN;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; FIBROBLASTS; HUMANS; KERATIN-10; KERATIN-14; KERATINOCYTES; PROTEIN BIOSYNTHESIS; RECOMBINANT PROTEINS; SKIN; TRYPSIN;

EID: 84896065039     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-013-9368-y     Document Type: Article

References (22)

1. Auger FA, Berthod F, Moulin V, Pouliot R, Germain L (2004) Tissue-engineered skin substitutes: from in vitro constructs to in vivo applications. Biotechnol Appl Biochem 39(3):263-275
2. Berthiaume F, Maguire TJ, Yarmush ML (2011) Tissue engineering and regenerative medicine: history, progress, and challenges. Annu Rev Chem Biomol Eng 2(1):403-430
3. Bocker W, Moll R, Poremba C, Holland R, van Diest PJ, Dervan P, Burger H, Wai D, Ina Diallo R, Brandt B, Herbst H, Schmidt A, Lerch MM, Buchwallow IB (2002) Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest 82(6):737-746
4. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J (1999) Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of smad 3. J Investig Dermatol 112(1):49-57
5. Cheng W, Yan-hua R, Fang-gang N, Guo-an Z (2011) The content and ratio of type I and III collagen in skin differ with age and injury. Afr J Biotechnol 10(13):2524-2529. doi: 10.5897/AJB10.1999
6. Ellerström C, Strehl R, Moya K, Andersson K, Bergh C, Lundin K, Hyllner J, Semb H (2006) Derivation of a xeno-free human embryonic stem cell line. Stem Cells 24(10):2170-2176
7. Guide to Good Manufacturing Practice for Medicinal Product (2004) PE 009-2. http://www.hpci.ch/files/documents/guidelines/hh-gl-gmp.pdf. Accessed 26 Nov 2012
8. Haack-Sorensen M, Friis T, Bindslev L, Mortensen S, Johnsen HE, Kastrup J (2008) Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Scand J Clin Lab Invest 68(3):192-203
9. Huang S, Deng T, Wang Y, Deng Z, He L, Liu S, Yang J, Jin Y (2008) Multifunctional implantable particles for skin tissue regeneration: preparation, characterization, in vitro and in vivo studies. Acta Biomater 4(4):1057-1066
10. Larouche D, Hayward C, Cuffley K, Germain L (2005) Keratin 19 as a stem cell marker in vivo and in vitro. Methods Mol Biol 289:103-110
11. Legg J, Jensen UB, Broad S, Leigh I, Watt FM (2003) Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis. Development 130(24):6049-6063
12. MacNeil S (2007) Progress and opportunities for tissue-engineered skin. Nature 445(7130):874-880
13. Mazlyzam AL, Aminuddin BS, Fuzina NH, Norhayati MM, Fauziah O, Isa MR, Saim L, Ruszymah BHI (2007) Reconstruction of living bilayer human skin equivalent utilizing human fibrin as a scaffold. Burns 33(3):355-363
14. Mazlyzam AL, Aminuddin BS, Saim L, Ruszymah BHI (2008) Human serum is an advantageous supplement for human dermal fibroblast expansion: clinical implications for tissue engineering of skin. Arch Med Res 39(8):743-752
15. Metcalfe AD, Ferguson MWJ (2007) Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J R Soc Interface 4(14):413-437
16. Muhd Fakhruddin BH, Aminuddin BS, Mazlyzam AL, Ruszymah BHI (2004) The effects of age on monolayer culture of human keratinocytes for future use in skin engineering. Med J Malaysia 59:182-183
17. Peter GS (2005) The role of skin substitutes in the treatment of burn injuries. Clin Dermatol 23(4):413-418
18. Ravanti L, Heino J, López-Otín C, Kähäri V-M (1999) Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem 274(4):2446-2455
19. Reis-Filho JS, Simpson PT, Martins A, Preto A, Gärtner F, Schmitt FC (2003) Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch Inter J Pathol 443(2):122-132
20. Roseti L, Serra M, Tigani D, Brognara I, Lopriore A, Bassi A, Fornasari P (2008) Cell manipulation in autologous chondrocyte implantation: from research to cleanroom. La Chirurgia degli Organi di Movimento 91(3):147-151
21. Shimizu H (2006) Shimizu's textbook of dermatology. http://www.derm- hokudai.jp/shimizu-dermatology/index.html.Accessed 26 Nov 2012
22. Van Erp PE, Rijzewijk JJ, Boezeman JB, Leenders J, de Mare S, Schalkwijk J, van de Kerkhof PC, Ramaekerst FC, Bauer FW (1989) Flow cytometric analysis of epidermal subpopulations from normal and psoriatic skin using monoclonal antibodies against intermediate filaments. Am J Pathol 135(5):865-870